Comment from Anonymous
AnonymousSupportBusiness
Summary: The commenter, a practice owner and operator, supports the inclusion of certain peptides on the bulk drug substances list to ensure patients have access to safe, regulated compounded medications. They argue that current restrictions are driving patients toward unregulated online sources and advocate for a regulated pathway to preserve the patient-provider relationship.
As a practice owner and operator, I am writing to support patient and provider access to safe, regulated compounded peptides. With the current ban, especially in Ohio, I am unable to legally prescribe our most popular, most effective, and safest peptides. So my patients are going online and getting them from unregulated, unsafe "pharmacies." The current ban is doing more harm than good at this point. When my patients were getting these medications from my practice, we could say with absolute certainty that what the label says matches what is in the vial. That is a crucial safety point that is now completely gone. And while we deter our patients from these sources, the current replacements are simply inferior.
Compounded peptides, prepared by accredited pharmacies under state and federal oversight, give providers and pharmacists important tools to care for their patients. Restricting access pushes patients toward an unregulated market and raises costs, which disproportionately affects people managing chronic conditions.
I urge the committee to support a safe, quality, and regulated pathway for these peptides so that the patient-provider relationship is preserved and care stays in accountable channels.
Thank you for your time and and for considering my comment.